UK and European markets are lower again today on concerns over coranavirus and US elections. There is also uncertainty regarding US stimulus talks and Brexit negotiations.
European stocks ended lower on Tuesday, extending losses from previous session on worries about economic growth amid continued surge in coronavirus cases and stricter lockdown measures. The FTSE 100 fell more than 1% to close at 5,729 on Tuesday, its lowest level since April 21st, as investors fear that a resurgence in coronavirus cases across Europe would hamper economic recovery, while the lack of progress on a Brexit trade deal continued to weigh on sentiment.
US stocks turned in a mixed performance during trading. While the Dow and the S&P 500 moved to the downside on the day, the tech-heavy Nasdaq ended the day firmly in positive territory. The mixed performance on the day came amid concerns about the recent spike in coronavirus cases as well as continued uncertainty about the prospects for a new stimulus bill. Investors digested a fall in the CB consumer confidence, better-than-expected earnings, mounting coronavirus infections, and fading hopes of more stimulus before the presidential election next week. Earnings reports from 3M, Caterpillar, Merck & Co, Pfizer and Advanced Micro Devices came in better than expectations
Disclaimer: ‘Where the business has expressed opinions, they are based on current market conditions, they may differ from those of other investment professionals and are subject to change without notice. The information contained within this communication is believed to be reliable but Realm Investment Management Limited does not warrant its completeness or accuracy. This communication is not intended as a recommendation to invest in any particular asset class, security or strategy. Regulatory requirements that require impartiality of investment/investment strategy recommendations are therefore not applicable nor are any prohibitions to trade before publication. The information provided is for illustrative purposes only, it should not be relied upon as recommendations to buy or sell investments.’